NCT02506959
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +18 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Refractory Plasma Cell Myeloma
Explore clinical trials studying Refractory Plasma Cell Myeloma. Study availability and eligibility vary by location and protocol.
55 public trials
4 recruiting studies
Refractory Plasma Cell Myeloma trial results
Completed
S1304, Carfilzomib and Dexamethasone for Treating Patients With Relapsed or Refractory Myeloma
NCT01903811
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +18 more
- Locations
-
- Fairbanks Memorial Hospital Fairbanks, Alaska, United States
- University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
- The University of Arizona Medical Center-University Campus Tucson, Arizona, United States
- Kaiser Permanente-Anaheim Anaheim, California, United States
Completed
Pembrolizumab and Radiation Therapy in Patients With Relapsed or Refractory Multiple Myeloma
NCT03267888
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +17 more
- Locations
-
- Emory University/Winship Cancer Institute Atlanta, Georgia, United States
NCT03829020
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Mayo Clinic Jacksonville, Florida, United States
- Mayo Clinic in Rochester Rochester, Minnesota, United States
NCT02119468
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Mayo Clinic Scottsdale, Arizona, United States
- City of Hope Medical Center Duarte, California, United States
- Emory University/Winship Cancer Institute Atlanta, Georgia, United States
- Mayo Clinic Rochester, Minnesota, United States
- Conditions
- Acute Leukemia, Blood Protein Disorders, Bone Marrow Diseases, +50 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
NCT02509052
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Completed
Panobinostat and Carfilzomib in Treating Participants With Relapsed or Refractory Multiple Myeloma
NCT01301807
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT03202628
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
NCT03338972
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States